Blasi, E <br/><br/>
Sunitinib, a receptor tyrosine kinase inhibitor, increases blood pressure in rats without associated changes in cardiac structure and function.  [electronic resource] 

 -  Cardiovascular therapeutics  Oct 2012 
 - 287-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1755-5922 
<br/><br/><label>Standard No.: </label>10.1111/j.1755-5922.2011.00278.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacokinetics<br/>Animals<br/>Blood Cell Count<br/>Blood Chemical Analysis<br/>Blood Pressure--drug effects<br/>Echocardiography<br/>Enzyme Inhibitors--therapeutic use<br/>Guinea Pigs<br/>Heart--anatomy & histology<br/>Heart Rate--drug effects<br/>In Vitro Techniques<br/>Indoles--metabolism<br/>Male<br/>Pyrroles--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Sunitinib<br/>Telemetry